Enterprise Europe Network

The Polish SME offers a system for the detection of pathogens’ genetic material under distribution services agreement or subcontracting agreement

Country of origin:
Country: 
POLAND
Opportunity:
External Id: 
BOPL20190819001
Published
20/08/2019
Last update
10/09/2019
Expiration date
10/09/2020

Keywords

Partner keyword: 
Bioinformatics
Gene Expression, Proteome Research
Population genetics
Diagnostic services
Molecular diagnosis
Other manufacturing n.e.c.
EXPRESS YOUR INTEREST

Summary

Summary: 
The Polish SME offers a system for the detection of pathogens’ genetic material (in particular DNA and/or ribonucleic acid) in a biological sample. The company would like to establish collaboration with other partners in order to acquire distributors. Moreover the SME is interested in healthcare industry partners for a subcontracting agreement.

Description

Description: 

The SME has developed an innovative solution that meets today’s business need in the diagnostic market. Instrument is a pocket-size molecular biology laboratory. The test material can be, e.g., whole blood, swab, cerebrospinal fluid. The proprietary, patented technology of controlling the processes occurring on the microfluidic card using photon energy is highly efficient. This enables the isothermal amplification and detection of pathogen-specific fragments of genetic material or mutations in a record time - less than 15 minutes and with an efficiency of 99%. Moreover, in the combination with the nucleic acid extraction and concentration procedure, the systems demonstrate a significant reduction in the DNA or RNA (ribonucleic acid) detection limit, thereby resulting in the recognition of infection at an earlier stage. The research may be subject to: bacteria, viruses, fungi, genetic mutations.

The Polish company will be one of the few producers of mobile molecular analyzers in the world as well as the only one on the European market. The company offers the first technology in the world based on the gold standards of the molecular diagnostics. This is a breakthrough solution, which does not require the support of experienced diagnostics or modern laboratories. Thanks to offered by SME solutions, the use of molecular technologies will be simpler than ever: it is enough to apply biological material to the reaction card and run the analyzer. First products intended for respiratory tract infections will be available in 2021 after gaining regulatory approval in EU.

In order to increase the performance of international coopearation the company is looking for the distribution services agreement. Moreover the SME is interested in healthcare industry for a subcontracting agreement. The subcontracting services are offered to companies that are not able to produce of mobile molecular analyzers and search for companies with skilled personnel and know-how or need the subcontractor for orders in diagnostic sphere.

Advantages & innovations

Cooperation plus value: 
The latest technology proprietary detection method used in device offers incredible ease of testing, without the need to use a specialist laboratory or employ diagnostics professionals. An intuitive and simple test (with extended shelf life and a possibility to store at room temperatures) can be performed by anyone without any prior training. The proposed technology further simplifies the diagnostic process, as it remains contained within a maintenance-free reaction card with the ability to detect up to 5 pathogens from a single sample. The entire process of analysis: from the application of biological material to the reaction card to the moment when final results are available will not require any additional equipment whatsoever. Thanks to offered by company solutions, the use of molecular technologies will be simpler than ever.

Stage of development

Cooperation stage dev stage: 
Available for demonstration

Partner sought

Cooperation area: 
The Polish SME is looking for distribution services agreement. The partner specified as distributor will be the sole distributor with the right to sell the product within a particular geographic region or within multiple regions. The distributor would sell the product to their own customers on exclusive or nonexclusive basis. The subcontracting service where Polish company is offering to become a subcontractor to interested healthcare sector companies abroad. The SME will provide its services as a subcontractor to companies that are not able to produce of mobile molecular analyzers and search for companies with skilled personnel and know-how or need the subcontractor for orders in diagnostic sphere.

Type and size

Cooperation task: 
SME 11-50,>500 MNE,251-500,SME 51-250,>500

Dissemination

Dissemination sector group : 
Dissemination preferred : 
China, France, Germany, Italy, Japan, United Kingdom, USA